Awarded in 2015
Home Department: Stem Cell Biology & Regenerative Medicine, Medicine
Faculty Advisors: Irving Weissman (Pathology, Developmental Biology), Michael Longaker (Surgery), Hermann Peter Lorenz (Surgery), and Geoffrey Gurtner (Surgery)

Research Description: Over 100 million patients acquire scars in the industrialized world each year. The global incidence of scarring is even greater, extending to significant numbers of burn and other trauma-related wounds. Beyond aesthetic considerations and potential disfigurement, scarring can result in restriction of movement and reduced quality of life. Graham’s research is centered on developing novel therapeutic approaches to scarring and fibrosis through the characterization and targeted inhibition of embryonic fibroblast lineages in the skin.

WHERE IS HE NOW?

Graham is a co-founder and Managing Partner of Logos Capital, a fundamental biotechnology-focused investment fund that seeks to combine in-house data analytics with scientific and clinical expertise to identify transformative therapies in healthcare.